RLE Group
RLE Group is a biotech startup with a mission to develop bioengineering solutions for healthy life extension. Founded by the scientist who proposed the 10th hallmark of aging and a group of biohackers known for their experiment to translate therapeutic plasma exchange on human beings.
Extend Life
radically
RLE Group
Extend Life
radically
RLE Group is a biotech startup with a mission to develop bioengineering solutions for healthy life extension.
RLE Group
RLE Group is a biotech startup with a mission to develop bioengineering solutions for healthy life extension. Founded by the scientist who proposed the 10th hallmark of aging and a group of biohackers known for their experiment to translate therapeutic plasma exchange on human beings.
Extend Life
radically
RLE Group
Extend Life
radically
RLE Group is a biotech startup with a mission to develop bioengineering solutions for healthy life extension. Founded by the scientist who proposed the 10th hallmark of aging and a group of biohackers known for their experiment to translate therapeutic plasma exchange on human beings.
Our Projects
Longevity gene delivery system
Safe and efficient gene delivery system based on a non-viral vector and silicon nanoparticles for gene therapy of aging. With the help of this system we could deliver a combination of several genes each of which extended lifespan of mice by up to 40%.
We developed a compound only several injections of which are capable of extending a lifespan of already aged mice by more than 10% by rejuvenating epigenetic signature of aged blood stems cells.
Restoration of Elastin
We are developing a genetic vector carrying all genes that are necessary for elastogenesis. This vector in conjunction with our gene delivery system will help to return elasticity to aged skin and potentially could be used to restore elasticity of other organs and tissues like heart, lungs and blood vessels.
CONTACT US
CONTACT US
CONTACT US
to get more details
to get more details
to get more details
to get more details
to get more details
to get more details
Epigenetic rejuvenation
LEARN MORE
Our Projects
With the help of this system we could deliver a combination of several genes each of which extended lifespan of mice by up to 40%.
Safe and efficient gene delivery system based on a non-viral vector and silicon nanoparticles for gene therapy of aging.
Project 1
Longevity gene delivery system
Project 2
We developed a compound only several injections of which are capable of extending a lifespan of already aged mice by more than 10% by rejuvenating epigenetic signature of aged blood stems cells.
Epigenetic rejuvenation
This vector in conjunction with our gene delivery system will help to return elasticity to aged skin and potentially could be used to restore elasticity of other organs and tissues like heart, lungs and blood vessels.
We are developing a genetic vector carrying all genes that are necessary for elastogenesis.
Project 3
Restoration of Elastin
to get more details
to get more details
Our Team
Yuri Khait, MSc
CEO
Dmitrii Sosin, PhD
nikolai sidorov
CSO
Alexander Fedintsev, MSc
Stanislav polozov, MSc
Director, Intellectual Property
Investor, Board Member
Principal Research Scientist
Core Members of the RLE group
Scientific advisers
Biogerontologist with 20+ years experience in Ageing Research
Biogerontologist, professor at Harvard Medical School
aleksei moskalev, PhD
leonid peshkin, PhD
Andrei Isaev, MD
Yuri Khait, MSc
CEO
dmitrii sosin, PhD
nikolai sidorov
Principal Research Scientist
CSO
Alexander Fedintsev, MSc
Stanislav polozov, MSc
Director, Intellectual Property
Investor, Board Member
CO-Founder
Biogerontologist with 20+ years experience in Ageing Research
Biogerontologist, professor at Harvard Medical School
aleksei moskalev, PhD
leonid peshkin, PhD
Our Team
Core Members of the RLE group
Scientific advisers
Andrei Isaev, MD
Yuri Khait, MSc
dmitrii sosin, PhD
nikolai sidorov
Alexander Fedintsev, MSc
Stanislav polozov, MSc
aleksei moskalev, PhD
leonid peshkin, PhD
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
Ellen Segal
Ambassador
Ellen Segal
Ambassador
Ellen Segal
Ambassador
Ellen Segal
Scientific Publications
The influence of pro-longevity gene Gclc overexpression on the age-dependent changes in Drosophila transcriptome and biological functions.
4.931 (2021)
Five year impact factor
Circadian clock genes’ overexpression in Drosophila alters diet impact on lifespan.
5.585 (2021)
Five year impact factor
The Resistance of Drosophila melanogaster to Oxidative, Genotoxic, Proteotoxic, Osmotic Stress, Infection, and Starvation Depends on Age According to the Stress Factor.
7.886 (2021)
Five year impact factor
11.005
Impact Factor
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.
Aging cell, 15(3), 407-415
Mar, 2016
Aging (Albany NY), 9(4), 1280
5.955
Impact Factor
Apr, 2017
Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.
11.788
Impact Factor
Stochastic non-enzymatic modification of long-lived macromolecules-A missing hallmark of aging.
Dec, 2016
BMC genomics, 17(14), 273-289
Biogerontology 20, 159–170
Apr, 2019
Antioxidants 2020, 9, 1239
Dec, 2020
Ageing Research Reviews, 62, 101097
Sep, 2020
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
READ MORE
Scientific Publications
READ MORE
Ageing Research Reviews, 62, 101097
Sep, 2020
11.788 Impact Factor
Stochastic non-enzymatic modification of long-lived macromolecules-A missing hallmark of aging.
READ MORE
5.955 Impact Factor
Aging (Albany NY), 9(4), 1280
Apr, 2017
Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.
READ MORE
11.005 Impact Factor
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.
Aging cell, 15(3), 407-415
Mar, 2016
READ MORE
4.931 (2021) 5 year impact factor
The influence of pro-longevity gene Gclc overexpression on the age-dependent changes in Drosophila transcriptome and biological functions.
Dec, 2016
BMC genomics, 17(14), 273-289
READ MORE
Circadian clock genes’ overexpression in Drosophila alters diet impact on lifespan.
Biogerontology 20, 159–170
Apr, 2019
5.585 (2021) 5 year impact factor
Antioxidants 2020, 9, 1239
Dec, 2020
7.886 (2021) 5 year impact factor
READ MORE
The Resistance of Drosophila melanogaster to Oxidative, Genotoxic, Proteotoxic, Osmotic Stress, Infection, and Starvation Depends on Age According to
the Stress Factor.
Scientific Publications
The Resistance of Drosophila melanogaster to Oxidative, Genotoxic, Proteotoxic, Osmotic Stress, Infection, and Starvation Depends on Age According to the Stress Factor.
Antioxidants 2020, 9, 1239
Dec, 2020
7.886 (2021) 5 year impact factor
READ MORE
READ MORE
Ageing Research Reviews, 62, 101097
Sep, 2020
11.788 Impact Factor
Stochastic non-enzymatic modification of long-lived macromolecules-A missing hallmark of aging.
READ MORE
5.955 Impact Factor
Aging (Albany NY), 9(4), 1280
Apr, 2017
Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.
READ MORE
4.931 (2021) 5 year impact factor
The influence of pro-longevity gene Gclc overexpression on the age-dependent changes in Drosophila transcriptome and biological functions.
Dec, 2016
BMC genomics, 17(14), 273-289
READ MORE
Circadian clock genes’ overexpression in Drosophila alters diet impact on lifespan.
Biogerontology 20, 159–170
Apr, 2019
5.585 (2021) 5 year impact factor
READ MORE
11.005 Impact Factor
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.
Aging cell, 15(3), 407-415
Mar, 2016
The Resistance of Drosophila melanogaster to Oxidative, Genotoxic, Proteotoxic, Osmotic Stress, Infection, and Starvation Depends on Age According to the Stress Factor.
Antioxidants 2020, 9, 1239
Dec, 2020
7.886 (2021) 5 year impact factor
READ MORE
READ MORE
Ageing Research Reviews, 62, 101097
Sep, 2020
11.788 Impact Factor
Stochastic non-enzymatic modification of long-lived macromolecules-A missing hallmark of aging.
READ MORE
5.955 Impact Factor
Aging (Albany NY), 9(4), 1280
Apr, 2017
Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.
READ MORE
11.005 Impact Factor
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.
Aging cell, 15(3), 407-415
Mar, 2016
READ MORE
4.931 (2021) 5 year impact factor
The influence of pro-longevity gene Gclc overexpression on the age-dependent changes in Drosophila transcriptome and biological functions.
Dec, 2016
BMC genomics, 17(14), 273-289
READ MORE
Circadian clock genes’ overexpression in Drosophila alters diet impact on lifespan.
Biogerontology 20, 159–170
Apr, 2019
5.585 (2021) 5 year impact factor
Media about us
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
Our team was the first to try therapeutic plasma exchange on humans. We tried it on ourselves, measured various biomarkers and noticed some positive changes. More details are in the article.
A recent article in “Fortune” magazine about
the prospects for overcoming aging refers, among others, to the work of our CSO A.Fedintsev, where he proposes the 10th hallmark of aging and claims that damage to long-lived proteins of the extracellular matrix may be a key driver of aging.
Media Coverage
Out for blood in the search to stall aging.
A gaggle of biotech start-ups are trying vastly different approaches to spin animal studies into the next big anti-aging therapy. It’s too early to know which, if any, will succeed.
A recent article in “Fortune” magazine about the prospects for overcoming aging fortune.com/2020/12/30/ anti-aging-research-health-care-spending-biden refers, among others, to the work of our group member A.Fedintsev, where one of the main causes of aging is damage to long-lived proteins of the extracellular matrix.
One of the main causes of aging.
About our experiment: Biohackers Perform First Plasma Dilution Experiment on Humans. A recent article in “Fortune” magazine about the prospects for overcoming aging fortune.com/2020/12/30/ anti-aging-research-health-care-spending-biden refers, among others, to the work of our group member A.Fedintsev, where one of the main causes of aging is damage to long-lived proteins of the extracellular matrix.
Plasma Dilution Experiment on Humans.
READ MORE
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
READ MORE
READ MORE
One of the main causes of aging.
A recent article in “Fortune” magazine about the prospects for overcoming aging refers, among others, to the work of our CSO A.Fedintsev, where he proposes the 10th hallmark of aging and claims that damage to long-lived proteins of the extracellular matrix may be a key driver of aging.
READ MORE
READ MORE
Plasma Dilution Experiment on Humans.
Our team was the first to try therapeutic plasma exchange on humans. We tried it on ourselves, measured various biomarkers and noticed some positive changes. More details are in the article.
READ MORE
READ MORE
Our CSO A. Fedintsev at Foresight Institute talks about biohacking and why it is an important component of a strategy for radical life extension.
Biohacking – A Necessary Component of a Strategy for Radical Life Extension - Foresight Institute.
Out for blood in the search to stall aging.
READ MORE
READ MORE
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
Media Coverage
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
Our team was the first to try therapeutic plasma exchange on humans. We tried it on ourselves, measured various biomarkers and noticed some positive changes. More details are in the article.
A recent article in “Fortune” magazine about the prospects for overcoming aging refers, among others, to the work of our CSO A.Fedintsev, where he proposes the 10th hallmark of aging and claims that damage to long-lived proteins of the extracellular matrix may be a key driver of aging.
Our CSO A. Fedintsev at Foresight Institute talks about biohacking and why it is an important component of a strategy for radical life extension.
One of the main causes of aging.
Plasma Dilution Experiment on Humans.
Biohacking – A Necessary Component of a Strategy for Radical Life Extension - Foresight Institute.
Out for blood in the search to stall aging.
READ MORE
READ MORE
READ MORE
READ MORE
Media Coverage
READ MORE
One of the main causes of aging.
A recent article in “Fortune” magazine about
the prospects for overcoming aging refers, among others, to the work of our CSO A.Fedintsev, where he proposes the 10th hallmark of aging and claims that damage to long-lived proteins of the extracellular matrix may be a key
driver of aging.
READ MORE
Plasma Dilution Experiment on Humans.
Our team was the first to try therapeutic plasma exchange on humans. We tried it on ourselves, measured various biomarkers and noticed some positive changes. More details are in the article.
Biohacking – A Necessary Component of a Strategy for Radical Life Extension - Foresight Institute.
Our CSO A. Fedintsev at Foresight Institute talks about biohacking and why it is an important component of a strategy for radical life extension.
READ MORE
Out for blood in the search to stall aging.
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
READ MORE
A recent article in “Fortune” magazine about
the prospects for overcoming aging refers, among others, to the work of our CSO A.Fedintsev, where he proposes the 10th hallmark of aging and claims that damage to long-lived proteins of the extracellular matrix may be a key driver of aging.
READ MORE
One of the main causes of aging.
READ MORE
Our team was the first to try therapeutic plasma exchange on humans. We tried it on ourselves, measured various biomarkers and noticed some positive changes. More details are in the article.
Plasma Dilution Experiment on Humans.
Biohacking – A Necessary Component of a Strategy for Radical Life Extension - Foresight Institute.
Our CSO A. Fedintsev at Foresight Institute talks about biohacking and why it is an important component of a strategy for radical life extension.
READ MORE
Out for blood in the search to stall aging.
Another article about our experiment of translating therapeutic plasma exchange from mice to humans.
READ MORE
© Copyright 2022 RLE Group. All rights reserved.
© Copyright 2022 RLE Group. All rights reserved.
"Anything less than immortality is a complete waste of time!" (Futurama). Yuri took this joke quite literally and decided that he has to beat aging first.
IT-entrepreneur, Master's degree in engineering.
About 10 years ago, Yuri got so interested in the question of life extension that it gradually became his top priority in life. In 2013 he created an informal structure, that eventually evolved into the RLEgroup project. Yuri is an experienced biohacker and tried almost every intervention that is known to extend lifespan of model organisms: from caloric restriction and physical excercises to senolytics and therapeutic plasma exchange. Some of these interventions look quite promising but even the most powerful of them are far from radical life extension. That was his main motivation to create this startup.
Yuri Khait, MSc
CEO
"Anything less than immortality is a complete waste of time!" (Futurama). Yuri took this joke quite literally and decided that he has to beat aging first.
IT-entrepreneur, Master's degree in engineering.
About 10 years ago, Yuri got so interested in the question of life extension that it gradually became his top priority in life. In 2013 he created an informal structure, that eventually evolved into the RLEgroup project. Yuri is an experienced biohacker and tried almost every intervention that is known to extend lifespan of model organisms: from caloric restriction and physical excercises to senolytics and therapeutic plasma exchange. Some of these interventions look quite promising but even the
most powerful of them are far from radical life extension. That was his main
motivation to create this startup.
Yuri Khait
CEO
IT-entrepreneur, Master's degree in engineering.
About 10 years ago, Yuri got so interested in the question of life extension that it gradually became his top priority in life. In 2013 he created an informal structure, that eventually evolved into the RLEgroup project. Yuri is an experienced biohacker and tried almost every intervention that is known to extend lifespan of model organisms: from caloric restriction and physical excercises to senolytics and therapeutic plasma exchange. Some of these interventions look quite promising but even the most powerful of them are far from radical life extension. That was his main motivation to create this startup.
Yuri Khait, MSc
CEO
Yuri Khait, MSc
After graduating with a Master's degree in computational biology from Kiev State University, Department of Molecular Biology and Genetics, he worked in the Institute of Molecular Oncology at the Hannover Medical School (MHH), Germany on the "Human Genome" project.
At that time he started to make his first engineering inventions (as of today he has more than 100 of them), e.g. he patented a computer display with subtractive color mixing (patent DE4443470A1). Remarkably, most modern display technologies use the same principle.
Stanislav Polozov
Director, Intellectual property
After graduating with a Master's degree in computational biology from Kiev State University, Department of Molecular Biology and Genetics, he worked in the Institute of Molecular Oncology at the Hannover Medical School (MHH), Germany on the "Human Genome" project. At that time he started to make his first engineering inventions (as of today he has more than 100 of them), e.g. he patented a computer display with subtractive color mixing (patent DE4443470A1). Remarkably, most modern display technologies use the same principle.
Stanislav Polozov
Director, Intellectual property
After graduating with a Master's degree in computational biology from Kiev State University, Department of Molecular Biology and Genetics, he worked in the Institute of Molecular Oncology at the Hannover Medical School (MHH), Germany.
At that time he started to make his first engineering inventions (for today he
has more than 100 of them), e.g. computer display with subtractive color mixing (patent DE4443470A1), the principle of which is used in
the most modern display technologies.
Stanislav Polozov
Director, Intellectual property
Alexander Fedintsev, MSc
"Every natural science contains as much truth as much mathematics it contains." Alexander agrees with Immanuel Kant and first learned how to evaluate the rate of aging mathematically.
Alexander is a biogerontologist recognized for his proposal of the 10th hallmark of aging. He is widely regarded as an expert in the aging of the extracellular matrix (ECM) and has put forth several hypotheses e. g. he thinks that stiffening of the ECM caused by glycation imitates fibrosis and causes cellular senescence. Currently, Alexander serves as Chief Scientific Officer of the Radical Life Extension group and is a member of the advisory board at Longaevus. Along with his expertise in theoretical geroscience, Alexander is also an accomplished machine learning specialist holding a title of a Staff Data Scientist at a large international company. He has co-authored numerous books on aging and geroprotectors, has developed a highly accurate non-invasive biomarker for aging based on cardiovascular markers and presented his works at various conferences.
CSO
Alexander Fedintsev
"Every natural science contains as much truth as much mathematics it contains." Alexander agrees with Immanuel Kant and first learned how to evaluate the rate of aging mathematically.
CSO
Alexander Fedintsev
Alexander is a biogerontologist recognized for his proposal of the 10th hallmark of aging. He is widely regarded as an expert in the aging of the extracellular matrix (ECM) and has put forth several hypotheses e. g. he thinks that stiffening of the ECM caused by glycation imitates fibrosis and causes cellular senescence. Currently, Alexander serves as Chief Scientific Officer of the Radical Life Extension group and is a member of the advisory board at Longaevus. Along with his expertise in theoretical geroscience, Alexander is also an accomplished machine learning specialist holding a title of a Staff Data Scientist at a large international company. He has co-authored numerous books on aging and geroprotectors, has developed a highly accurate non-invasive biomarker for aging based on cardiovascular markers and presented his works at various conferences.
Alexander is a biogerontologist recognized for his proposal of the 10th hallmark of aging. He is widely regarded as an expert in the aging of the extracellular matrix (ECM) and has put forth several hypotheses e. g. he thinks that stiffening of the ECM caused by glycation imitates fibrosis and causes cellular senescence. Currently, Alexander serves as Chief Scientific Officer of the Radical Life Extension group and is a member of the advisory board at Longaevus. Along with his expertise in theoretical geroscience, Alexander is also an accomplished machine learning specialist holding a title of a Staff Data Scientist at a large international company. He has co-authored numerous books on aging and geroprotectors, has developed a highly accurate non-invasive biomarker for aging based on cardiovascular markers and presented his works at various conferences.
Founder and CEO one of the largest Russian commercial laboratory network “DNKOM” and the network of medical centers “Medgorod”. Pediatrician, graduated from the Russian State Medical University in 2006. He worked in the department of infectious diseases in Moscow Morozov Children's Hospital. After that he was the head of the commercial division of the Central Research Institute of Epidemiology. In 2009 he organized his own project.
He is the author of a number of scientific and medical studies, including the first in Russia study of the dynamics of the development of the immune response in patients with Covid-19. Research interests - anti-age medicine, anti-aging.
Andrei Isaev, MD
CO-Founder
"The best clinical trial is self-trial. Following this principle, Nikolai has every chance to become the first ageless person on Earth."
Nikolay has a master's degree in psychology from Yaroslavl State University. Being a skilled expert in social psychology, he worked in the highest state bodies of the Russian Federation, ex-vice-governor of the Primorsky Krai of the Russian Federation. He is a member of the board of the Foundation for Technological Modernization and Development.
Nikolay is an uncompromising researcher of new approaches in anti-aging therapy. He has personally tested almost all available methods of slowing down aging - complete replacement of microbiota, all known senolytics, plasmapheresis and much more.
Nikolay Sidorov
CO-Founder
Dmitrii holds a PhD in molecular biology and has an extensive research experience - he worked for more than 15 years in the Institute of Molecular Biology. He also has an experience of leading a research group. In addition to that, he has a very successful mentorship experience: under his supervision team from MEPhI won a bronze medal in a prestigious iGEM competition in 2021. His research interests are epigenetics and gene delivery systems - he is an inventor of a silicon nanoparticles technology for efficient gene delivery.
Dmitrii Sosin, PhD
Principal Research Scientist
Dmitrii holds a PhD in molecular biology and has an extensive research experience - he worked for more than 15 years in the Institute of Molecular Biology. He also has an experience of leading a research group. In addition to that, he has a very successful mentorship experience: under his supervision team from MEPhI won a bronze medal in a prestigious iGEM competition in 2021. His research interests are epigenetics and gene delivery systems - he is an inventor of a silicon nanoparticles technology for efficient gene delivery.
Dmitrii Sosin, PhD
Principal Research Scientist
"Every natural science contains as much truth as much mathematics it contains." Alexander agrees with Immanuel Kant and first learned how to evaluate the rate of aging mathematically."
Dmitrii holds a PhD in molecular biology and has an extensive research experience - he worked for more than 15 years in the Institute of Molecular Biology. He also has an experience of leading a research group. In addition to that, he has a very successful mentorship experience: under his supervision team from MEPhI won a bronze medal in a prestigious iGEM competition in 2021. His research interests are epigenetics and gene delivery systems - he is an inventor of a silicon nanoparticles
technology for efficient gene delivery.
Dmitrii Sosin, PhD
He is a well-known specialist in the field of genetics of aging and radiation genetics with more than 100 publications in those areas. Dr. Moskalev was focusing on the effect of low dose ionizing radiation on lifespan and aging of various Drosophila strains. Alexey spent over 20 years studying mechanisms of aging, longevity, and stress resistance in animal models, including DNA repair, heat shock proteins, NF-kB, Tor- and PI3K-signaling cascade, apoptosis. Alexey participated in the work of identifying mechanisms of exceptional longevity of Myotis brandtii bats and grey whale mammalian species. He was also a contributor in creating a database of biomarkers of aging Digital Ageing Atlas and databases of anti-aging drugs.
Aleksei Moskalev, PhD
Scientific Adviser
Russian scientist-biogerontologist, specialist in the field of genetics of longevity and aging, studies the mechanisms of regulation of the rate of aging and longevity. Doctor of Biological Sciences, Professor, Professor of the Russian Academy of Sciences, Corresponding Member of the Russian Academy of Sciences. Graduated from Syktyvkar State University. He works at the Institute of Biology of the Ural Branch of the Russian Academy of Sciences, the Gerontological Research and Clinical Center and the Institute of Molecular Biology named after V.I. V.A. Engelhardt.
Aleksei Moskalev, PhD
Scientific Adviser
He is a well-known specialist in the field of genetics of aging and radiation genetics with more than 100 publications in those areas. Dr. Moskalev was focusing on the effect of low dose ionizing radiation on lifespan and aging of various Drosophila strains. Alexey spent over 20 years studying mechanisms of aging, longevity, and stress resistance in animal models, including DNA repair, heat shock proteins, NF-kB, Tor- and PI3K-signaling cascade, apoptosis. Alexey participated in the work of identifying mechanisms of exceptional longevity of Myotis brandtii bats and grey whale mammalian species. He was also a contributor in creating a database of biomarkers of aging Digital Ageing Atlas and databases of anti-aging drugs.
Aleksei Moskalev, PhD
He is a well-known specialist in the field of genetics of aging and radiation genetics with more than 100 publications in those areas. Dr. Moskalev was focusing on the effect of low dose ionizing radiation on lifespan and aging of various Drosophila strains. Alexey spent over 20 years studying mechanisms of aging, longevity, and stress resistance in animal models, including DNA repair, heat shock proteins, NF-kB, Tor- and PI3K-signaling cascade, apoptosis. Alexey participated in the work of identifying mechanisms of exceptional longevity of Myotis brandtii bats and grey whale mammalian species. He was also a contributor in creating a database of biomarkers of aging Digital Ageing Atlas and databases of anti-aging drugs.
He is a well-known specialist in the field of genetics of aging and radiation genetics with more than 100 publications in those areas. Dr. Moskalev was focusing on the effect of low dose ionizing radiation on lifespan and aging of various Drosophila strains. Alexey spent over 20 years studying mechanisms of aging, longevity, and stress resistance in animal models, including DNA repair, heat shock proteins, NF-kB, Tor- and PI3K-signaling cascade, apoptosis. Alexey participated in the work of identifying mechanisms of exceptional longevity of Myotis brandtii bats and grey whale mammalian species. He was also a contributor in creating a database of biomarkers of aging Digital Ageing Atlas and databases of anti-aging drugs.
Lecturer in the Department of Systems Biology at Harvard Medical School, also part of the Marine Biological Laboratory. He holds a PhD in Artificial Intelligence from Brown University and an MSc in Applied Mathematics from the Weizmann Institute of Science. Current research interests include embryology, evolution and aging. Leon's research on aging and personal history was highlighted in a recent Boston Globe article. His personal genome is used as the human genome standard by the US National Standards Institute in the Genome in a Bottle program, as described in an article in the journal Genome.
Leonid Peshkin, PhD
Scientific Adviser
Lecturer in the Department of Systems Biology at Harvard Medical School, also part of the Marine Biological Laboratory. He holds a PhD in Artificial Intelligence from Brown University and an MSc in Applied Mathematics from the Weizmann Institute of Science. Current research interests include embryology, evolution and aging. Leon's research on aging and personal history was highlighted in a recent Boston Globe article. His personal genome is used as the human genome standard by the US National Standards Institute in the Genome in a Bottle program, as described in an article in the journal Genome.
Leonid Peshkin, PhD
Scientific Adviser
Lecturer in the Department of Systems Biology at Harvard Medical School, also part of the Marine Biological Laboratory. He holds a PhD in Artificial Intelligence from Brown University and an MSc in Applied Mathematics from the Weizmann Institute of Science. Current research interests include embryology, evolution and aging. Leon's research on aging and personal history was highlighted in a recent Boston Globe article. His personal genome is used as the human genome standard by the US National Standards Institute in the Genome in a Bottle program, as described in an article in the journal Genome.
Leonid Peshkin, PhD
Made on
Tilda